serw-MX  [xml]  
 


    
 DeCS Categories

C10 Nervous System Diseases .
C10.500 Nervous System Malformations .
C10.500.507 Malformations of Cortical Development .
C10.500.507.400 Malformations of Cortical Development, Group I .
C10.500.507.450 Malformations of Cortical Development, Group II .
C10.500.507.500 Malformations of Cortical Development, Group III .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.131 Congenital Abnormalities .
C16.131.666 Nervous System Malformations .
C16.131.666.507 Malformations of Cortical Development .
C16.131.666.507.400 Malformations of Cortical Development, Group I .
C16.131.666.507.450 Malformations of Cortical Development, Group II .
C16.131.666.507.500 Malformations of Cortical Development, Group III .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.464 Ligases .
D08.811.464.938 Ubiquitin-Protein Ligase Complexes .
D08.811.464.938.750 Ubiquitin-Protein Ligases .
D08.811.464.938.750.210 Inhibitor of Apoptosis Proteins .
D08.811.464.938.750.210.500 Neuronal Apoptosis-Inhibitory Protein .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.360 Intracellular Signaling Peptides and Proteins .
D12.644.360.075 Apoptosis Regulatory Proteins .
D12.644.360.075.437 Inhibitor of Apoptosis Proteins .
D12.644.360.075.437.500 Neuronal Apoptosis-Inhibitory Protein .
D12.776 Proteins .
D12.776.476 Intracellular Signaling Peptides and Proteins .
D12.776.476.075 Apoptosis Regulatory Proteins .
D12.776.476.075.437 Inhibitor of Apoptosis Proteins .
D12.776.476.075.437.500 Neuronal Apoptosis-Inhibitory Protein .
D12.776.631 Nerve Tissue Proteins .
D12.776.631.642 Neuronal Apoptosis-Inhibitory Protein .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Malformations of Cortical Development, Group I .
Abnormal Proliferation Cortical Malformations .
Cortical Malformations, Group I .
Malformations Due to Abnormal Neuronal and Glial Proliferation or Apoptosis .
Malformations Secondary to Abnormal Neuronal and Glial Proliferation or Apoptosis .
Cortical malformations secondary to abnormal neuronal and glial CELL PROLIFERATION or APOPTOSIS in NEUROGENESIS. This group includes congenital MICROCEPHALIES; MICROLISSENCEPHALIES, megalencephalies, HEMIMEGALENCEPHALIES and cortical dysplasias with balloon cells. .
1.00
094
 
Malformations of Cortical Development, Group II .
Cortical Malformations, Group II .
Malformations Due to Abnormal Neuronal Migration .
Malformations Secondary to Abnormal Neuronal Migration .
Disorder, Neuronal Migration .
Disorders, Neuronal Migration .
Migration Disorder, Neuronal .
Migration Disorders, Neuronal .
Neuronal Migration Disorder .
Neuronal Migration Disorders .
Cortical malformations secondary to abnormal neuronal CELL MIGRATION in NEUROGENESIS. This group includes COBBLESTONE LISSENCEPHALY and PERIVENTRICULAR NODULAR HETEROTOPIA. .
0.63
466
 
Malformations of Cortical Development, Group III .
Cortical Malformations, Group III .
Malformations Due to Abnormal Postmigrational Development .
Malformations Secondary to Abnormal Postmigrational Development .
Cortical malformations secondary to abnormal cortical maturation after CELL MIGRATION in NEUROGENESIS. This group includes injury to the cortex during later stages of cortical development such as POLYMICROGYRIA and focal cortical dysplasias. .
0.47
05
 
Malformations of Cortical Development .
Cerebral Cortical Dysplasia .
Cortical Dysplasia .
Cortical Dysplasia, Cerebral .
Malformations of Cerebral Cortex Development .
Cerebral Cortical Dysplasias .
Cortical Development Malformation .
Cortical Development Malformations .
Cortical Dysplasias .
Cortical Dysplasias, Cerebral .
Development Malformation, Cortical .
Development Malformations, Cortical .
Dysplasia, Cerebral Cortical .
Dysplasia, Cortical .
Dysplasias, Cerebral Cortical .
Dysplasias, Cortical .
Abnormalities in the development of the CEREBRAL CORTEX. These include malformations arising from abnormal neuronal and glial CELL PROLIFERATION or APOPTOSIS (Group I); abnormal neuronal migration (Group II); and abnormal establishment of cortical organization (Group III). Many INBORN METABOLIC BRAIN DISORDERS affecting CNS formation are often associated with cortical malformations. They are common causes of EPILEPSY and developmental delay. .
0.45
231073
 
/abnormalities .
/agenesis .
/anomalies .
/aplasia .
/atresia .
/birth defects .
/congenital defects .
/defects .
/deformities .
/hypoplasia .
/malformations .
Used with organs for congenital defects producing changes in the morphology of the organ. It is used also for abnormalities in animals. .
0.40
 
Neuronal Apoptosis-Inhibitory Protein .
NAIP Protein .
Apoptosis-Inhibitory Protein, Neuronal .
Neuronal Apoptosis Inhibitory Protein .
An inhibitor of apoptosis protein that was initially identified during analysis of CHROMOSOME DELETIONS associated with SPINAL MUSCULAR ATROPHY. Naip contains a nucleotide binding oligomerization domain and a carboxy-terminal LEUCINE rich repeat. .
0.37
1316